Safety of Intranodal ECI-006 in Melanoma Patients
Clinical trial NCT03394937 · TERMINATED
Trial details
- NCT number
- NCT03394937
- Sponsor
- eTheRNA immunotherapies
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2020-12-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.